SLNO SOLENO THERAPEUTICS INC

8-K Current Report

Filed: March 16, 2026

Health Care

Pharmaceutical Preparations

SOLENO THERAPEUTICS INC (SLNO) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.03: Amendments to Articles of Incorporation or Bylaws

AI Filing Analysis
8-K

Item 5.03 · Amendments to Articles of Incorporation or Bylaws

• Bylaws amended Mar 16, 2026: tightened advance notice requirements for stockholder proposals and director nominations
• Added exclusive forum selection provision — limits where stockholders can bring certain legal claims against the company

+1 more insights

Other SOLENO THERAPEUTICS INC 8-K Filings

8-K Feb 26, 2026

8-K Feb 25, 2026

Get deeper insights on SOLENO THERAPEUTICS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.